85 related articles for article (PubMed ID: 7518650)
1. Criteria for use of interferon alfa-2a or interferon alfa-2b for selected indications in adults.
Am J Hosp Pharm; 1994 Apr; 51(8):1030-3. PubMed ID: 7518650
[No Abstract] [Full Text] [Related]
2. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
Stuart-Harris RC; Lauchlan R; Day R
Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
[TBL] [Abstract][Full Text] [Related]
3. Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.
Rokx C; van der Ende ME; Verbon A; Rijnders BJ
Clin Infect Dis; 2013 Nov; 57(10):1497-9. PubMed ID: 23912848
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
Molloy PJ; Azzouz M; Van Thiel DH
Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
[TBL] [Abstract][Full Text] [Related]
6. AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?
Krown SE
Cytokine Growth Factor Rev; 2007; 18(5-6):395-402. PubMed ID: 17656146
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection.
Itri LM; Campion M; Dennin RA; Palleroni AV; Gutterman JU; Groopman JE; Trown PW
Cancer; 1987 Feb; 59(3 Suppl):668-74. PubMed ID: 10822468
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata].
Hohenleutner U; Landthaler M; Braun-Falco O
Hautarzt; 1990 Oct; 41(10):545-8. PubMed ID: 2258297
[TBL] [Abstract][Full Text] [Related]
9. Natural history and therapy of hepatitis B and C in patients with HIV disease.
Bernstein BM; Gill JC
AIDS Clin Rev; 1993-1994; ():129-43. PubMed ID: 8217896
[No Abstract] [Full Text] [Related]
10. Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata.
Cardamakis EK; Kotoulas IG; Dimopoulos DP; Stathopoulos EN; Michopoulos JT; Tzingounis VA
Arch Gynecol Obstet; 1996; 258(1):35-41. PubMed ID: 8789431
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic possibilities of recombinant interferon alfa-2b (Intron A) in non-AIDS Kaposi sarcomas and angiosarcomas].
Jelić S; Vuletić L; Filipović I; Milanović N; Tomasević Z; Marinković M
Glas Srp Akad Nauka Med; 1994; (44):117-25. PubMed ID: 7590408
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.
Ueno T; Mitsuishi T; Kimura Y; Kato T; Hasegawa H; Katano H; Sata T; Kurane S; Kawana S
Eur J Dermatol; 2007; 17(6):539-40. PubMed ID: 17951139
[No Abstract] [Full Text] [Related]
13. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
[TBL] [Abstract][Full Text] [Related]
14. Intralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin application.
Boot JM; Blog FB; Stolz E
Genitourin Med; 1989 Jan; 65(1):50-3. PubMed ID: 2921053
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C: limits and dose regimen of interferon alfa.
Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with recombinant interferon alfa-2a and pregnancy in a patient with chronic viral hepatitis C].
Masbou J; Larrey D; Michel H
Gastroenterol Clin Biol; 1995 Nov; 19(11):961-2. PubMed ID: 8746065
[No Abstract] [Full Text] [Related]
17. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment of extensive condylomata acuminata with interferon alfa-2b.
Grablowitz D; Micksche M; Söltz-Szöts J
J Am Acad Dermatol; 1992 Jun; 26(6):1009-10. PubMed ID: 1607400
[No Abstract] [Full Text] [Related]
19. Opportunistic infections update.
Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
[TBL] [Abstract][Full Text] [Related]
20. [Intermittent interferon alfa in the treatment of hairy cell leukemia].
Gómez-Almaguer D; Jaime-Pérez JC; Herrera-Garza JL; González-Llano O
Rev Invest Clin; 1998; 50(4):331-4. PubMed ID: 9830322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
